The Acceleration Consortium is leading a paradigm shift in scientific discovery through the development of self-driving artificial intelligence-guided robotic labs that accelerate the discovery of advanced materials and small molecules, from decades to years.
The consortium addresses fundamental topics, such as deep learning algorithms, materials modelling, and robotics and applied challenges, such as discovering materials for a wide range of commercial applications.
The Acceleration Consortium supports a commercialization-focused ecosystem that aims to translates materials discoveries through start-ups and industry partnerships.
The Centre for Research and Applications in Fluidic Technologies (CRAFT) is a unique long-term partnership between the University of Toronto (U of T) and Canada’s National Research Council to advance the field of microfluidics — the manipulation of fluids at micron length scales by developing devices with improved precision, lower detection limits, and the capacity to parallelize procedures. This partnership positions Canada to become a world-leader in developing and translating microfluidic solutions, such as point-of-care diagnostics, organ-on-a-chip devices and organ-scale tissue substitutes, that will improve the health of all Canadians and lay the foundation of a thriving, internationally competitive industry sector.
The Critical Digital Humanities Initiative (CDHI) enables trans-disciplinary collaborations that emphasize questions of power, social justice, and critical theory in digital humanities research. Its vision is to harness the very tools of the digital revolution to forge a new paradigm of critical humanities scholarship, one that bridges the humanities’ emphasis on power and culture in historical perspective with the tools and analysis of digital technology. The CDHI is new mix of research workshop and design atelier, equipping humanities researchers with the technical and design expertise to use digital tools to ask new questions, share new knowledge, and analyze power and inequality in historical perspective.
The Emerging and Pandemic Infections Consortium (EPIC) harnesses the full potential of Toronto’s diverse community, at U of T and its partner hospitals, of clinicians, scientists, engineers, and public health and policy-focused infectious disease experts to converge on innovative approaches that ensure future emerging infections do not wreak devastation. Anchored by U of T’s Infectious Disease Laboratories (IDL), Toronto’s only Combined Containment Level 3 (C-CL3) unit for the study of high-risk human pathogens, as well as the CL2+ aerosol containment facility and Biobank, EPIC’s virtual research and training ecosystem aims to be the leading initiative on infectious disease research and training from discovery to policy, a magnet for world-leading talent, and an authority on infectious disease-focused education and science-based advocacy.
The goal of the Indigenous Research Network is to build an interconnected and collaborative community of researchers involved in Indigenous research at U of T that respects and honours Indigenous cultures, knowledge, past and present. This multi-campus, multi-dimensional network will include faculty members and staff involved in research related to the challenges Indigenous Peoples and communities face and will promote curricular transformations required to address these challenges.
Transportation and mobility touch virtually all aspects of our lives. The Innovative Mobility Lab (IML) is a multidisciplinary, collaborative, and diverse network of mobility researchers that connects the University of Toronto’s exceptional strengths in data sciences, engineering and social sciences to address the technological, social, environmental and heath disruptions facing society globally. Through interdisciplinary basic and applied research IML will identify pathways to more equitable and efficient urban mobility, provide the evidence and decision-support needed for effective and lasting societal change, and have profound implications for individual well-being, resilient, sustainable and just urban growth and prosperity, and, ultimately, our planet’s future.
Medicine by Design brings together more than 130 leading researchers at U of T and its affiliated hospitals at the convergence of science, engineering and medicine to advance regenerative medicine discoveries and dramatically improve health outcomes. Created in 2015 with an unprecedented $114-million investment from the federal government’s Canada First Research Excellence Fund, Medicine by Design marks a new chapter in Toronto’s long history of global excellence in regenerative medicine, positioning Canada to continue to lead the field for decades to come.
There is a substantial gap in research evidence on the mental health and wellness needs of university students, raising critical questions about how to best support student mental health and wellness throughout their academic journey. The Student & Youth Mental Health Research Initiative will leverage important partnerships between U of T, the Centre for Addiction and Mental Health, and other hospital and community partners to establish a network of experts in student mental health research. Engaging with a wide range of stakeholders, this initiative will generate research-informed, evidence-based solutions to the complex challenges identified by the 2019 U of T Presidential & Provostial Task Force on Student Mental Health.
The Mitochondrial Innovation Initiative (MITO2i) is a network of researchers, clinicians, patients and advocates, academic institutions, non-governmental organizations and industry partners working together to transform our understanding of the role of mitochondria in human health and disease, including both rare and common chronic diseases affecting mood, metabolism, longevity and quality of life. MITO2i is focused on developing infrastructure for collaboration, knowledge integration and coordinated data-sharing to enable a comprehensive, big-picture understanding of this crucial and emerging area of medicine.
PRiME leverages the U of T’s world-class expertise in biologics, omics, molecular chemistry, liquid biopsy, nanomedicine, biology-on-a-chip and related domains to develop new solutions to unmet needs in human disease. The multidisciplinary approach at PRiME goes beyond genomics and mutational profiling, to more fully understand the biology of disease, create new tools for disease diagnosis, and develop novel therapeutic strategies that will deliver on the promise of precision medicine.
The University of Toronto Robotics Institute is Canada’s global robotics talent network. UofT faculty working across the frontiers of robotics innovation have a critical mass of expertise spanning the robotics-enabling technologies (sensors, controls, machine learning and AI), robot system integration (perception and control), robot applications (healthcare, manufacturing, and mobility) and their impacts (business, ethical, regulatory, and economic). With a breadth comparable to many of the leading robotics research centres worldwide, and an alumni network that spans the globe, the University of Toronto Robotics Institute is Canada’s leading research and training partner in advanced robotics and thought leadership. Together with our partner ecosystem, we bring UofT research excellence and values to the global forefront of robotics innovation.
The School of Cities convenes interdisciplinary urban-focused researchers, educators, students, practitioners, institutions and the general public to explore and address complex urban challenges, with the aim of making cities, urban regions and communities more equitable, sustainable, prosperous and just. Today, more than half of the world’s population lives in cities. Why do cities matter? What makes a city livable? What do we need to do to make cities more sustainable, inclusive and just? U of T’s physical location in Canada’s largest city, and deep urban-focused expertise across all fields uniquely positions the School of Cities to examine these questions and address the challenges cities are expected to face in the years to come.
The Schwartz Reisman Institute for Technology and Society is a research and solutions hub dedicated to ensuring that powerful technologies like artificial intelligence are safe, fair, ethical, and make the world better—for everyone. With researchers in fields ranging from law, philosophy, and political science to computer science, engineering and beyond, the Institute will develop new frameworks to understand the social implications of technologies in the present age, and reinvent laws, institutions, and social values to ensure technology is designed, governed, and deployed to deliver a more just and inclusive world.
The Ted Rogers Centre for Heart Research aims to transform and dramatically improve the future of heart health for children, adults and families across Canada and around the world, through an integrated program of outstanding research, education, and clinical care. The Centre provides global leadership in the cardiac field and attracts research and clinical talent to enable new diagnostics, treatments, and tools to help people prevent, manage, and survive the devastating consequences of heart failure.
The Toronto Cannabis and Cannabinoid Consortium (TC3) is a tri-campus, multi-institution, interdisciplinary Institutional Strategic Initiative that aims to advance cannabis and cannabinoid research across U of T and the Toronto Academic Health Sciences Network through research, education and training, resource sharing and collaboration, and knowledge translation and partnerships. The TC3 endeavours to close the significant gaps in knowledge related to the benefits, harms, and opportunities of cannabis and cannabinoid use and to develop a pipeline of highly qualified personnel who will become leaders in research and innovation in cannabis health sciences, business and policy. Together with our hospital partners, we are poised to take the lead as a cannabis knowledge creator and broker and make a national and international impact on health, policy and the economy.
|TRANSFORM-HF is a collaboration between the University of Toronto and the Ted Rogers Centre for Heart Research.|
TRANSFORM-Heart Failure aims to enable new healthcare models that are proactive, personalized, and decentralized to improve access to equitable, high-quality heart failure care. TRANSFORM-HF unites a diverse team of experts in technology innovation and implementation, basic science, heart failure medicine, data analytics and artificial intelligence, health technology assessment, patient engagement and Indigenous health focused on working collaboratively to advance digital medicine and remote healthcare monitoring technologies in service of its mission. Together with Indigenous organizations and leaders, as well as patients, TRANSFORM-HF hopes to create such innovative models in a spirit of allyship and partnership.